Genitourinary Cancer

Top Story

Toxic effects of immunotherapy ‘a valid concern’ among oncology experts

January 11, 2018
FDA News

FDA grants breakthrough therapy designation to Lenvima plus Keytruda for renal cell carcinoma

January 9, 2018
The FDA granted breakthrough therapy designation to lenvatinib mesylate in combination with pembrolizumab for the treatment of patients with advanced or metastatic renal…
In the Journals Plus

US cancer deaths continue to decline, but racial disparities persist

January 4, 2018
The cancer mortality rate dropped 1.7% from 2014 to 2015, continuing a decades-long decline reaching 26% since 1991, according to Cancer Statistics 2018, the American…

ASCO announces new membership roles

December 31, 2017
Five ASCO members have been elected to the society’s board of directors to fill existing vacancies. The new members will serve 4-year terms beginning in June 2018.
More Headlines »

Ace the Case: 61-Year-Old Male Who Presents to the ER with Worsening Back Pain

There is no commercial support for this activity.

This “Ace the Case” activity will review the diagnosis and management of patients with high-risk multiple…
More »

Baseball Hall of Famer Mike Schmidt promotes sun protection, skin cancer awareness

September 28, 2017
More »
Resource Centers
San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium


Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »